KEGG   PATHWAY: hsa04622Help
Entry
hsa04622                    Pathway                                

Name
RIG-I-like receptor signaling pathway - Homo sapiens (human)
Description
Specific families of pattern recognition receptors are responsible for detecting viral pathogens and generating innate immune responses. Non-self RNA appearing in a cell as a result of intracellular viral replication is recognized by a family of cytosolic RNA helicases termed RIG-I-like receptors (RLRs). The RLR proteins include RIG-I, MDA5, and LGP2 and are expressed in both immune and nonimmune cells. Upon recognition of viral nucleic acids, RLRs recruit specific intracellular adaptor proteins to initiate signaling pathways that lead to the synthesis of type I interferon and other inflammatory cytokines, which are important for eliminating viruses.
Class
Organismal Systems; Immune system
BRITE hierarchy
Pathway map
RIG-I-like receptor signaling pathway
hsa04622

All organismsOrtholog table
Disease
H00827  
Brooke-Spiegler syndrome
H00882  
Cocoon syndrome
Organism
Homo sapiens (human) [GN:hsa]
Gene
23586  
DDX58; DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 [KO:K12646] [EC:3.6.3.14]
64135  
IFIH1; interferon induced with helicase C domain 1 [KO:K12647] [EC:3.6.4.13]
57506  
MAVS; mitochondrial antiviral signaling protein [KO:K12648]
79132  
DHX58; DEXH (Asp-Glu-X-His) box polypeptide 58 [KO:K12649] [EC:3.6.3.14]
7187  
TRAF3; TNF receptor-associated factor 3 [KO:K03174]
10010  
TANK; TRAF family member-associated NFKB activator [KO:K12650]
64343  
AZI2; 5-azacytidine induced 2 [KO:K12651]
9755  
TBKBP1; TBK1 binding protein 1 [KO:K12652]
8517  
IKBKG; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma [KO:K07210]
29110  
TBK1; TANK-binding kinase 1 [KO:K05410] [EC:2.7.11.10]
9641  
IKBKE; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon [KO:K07211] [EC:2.7.11.10]
3661  
IRF3; interferon regulatory factor 3 [KO:K05411]
3665  
IRF7; interferon regulatory factor 7 [KO:K09447]
3439  
IFNA1; interferon, alpha 1 [KO:K05414]
3440  
IFNA2; interferon, alpha 2 [KO:K05414]
3441  
IFNA4; interferon, alpha 4 [KO:K05414]
3442  
IFNA5; interferon, alpha 5 [KO:K05414]
3443  
IFNA6; interferon, alpha 6 [KO:K05414]
3444  
IFNA7; interferon, alpha 7 [KO:K05414]
3445  
IFNA8; interferon, alpha 8 [KO:K05414]
3446  
IFNA10; interferon, alpha 10 [KO:K05414]
3447  
IFNA13; interferon, alpha 13 [KO:K05414]
3448  
IFNA14; interferon, alpha 14 [KO:K05414]
3449  
IFNA16; interferon, alpha 16 [KO:K05414]
3451  
IFNA17; interferon, alpha 17 [KO:K05414]
3452  
IFNA21; interferon, alpha 21 [KO:K05414]
3456  
IFNB1; interferon, beta 1, fibroblast [KO:K05415]
3467  
IFNW1; interferon, omega 1 [KO:K05440]
338376  
IFNE; interferon, epsilon [KO:K05442]
56832  
IFNK; interferon, kappa [KO:K05441]
8717  
TRADD; TNFRSF1A-associated via death domain [KO:K03171]
8772  
FADD; Fas (TNFRSF6)-associated via death domain [KO:K02373]
8737  
RIPK1; receptor (TNFRSF)-interacting serine-threonine kinase 1 [KO:K02861] [EC:2.7.11.1]
841  
CASP8; caspase 8, apoptosis-related cysteine peptidase [KO:K04398] [EC:3.4.22.61]
843  
CASP10; caspase 10, apoptosis-related cysteine peptidase [KO:K04400] [EC:3.4.22.63]
1147  
CHUK; conserved helix-loop-helix ubiquitous kinase [KO:K04467] [EC:2.7.11.10]
3551  
IKBKB; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta [KO:K07209] [EC:2.7.11.10]
4793  
NFKBIB; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta [KO:K02581]
4792  
NFKBIA; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha [KO:K04734]
4790  
NFKB1; nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 [KO:K02580]
5970  
RELA; v-rel reticuloendotheliosis viral oncogene homolog A (avian) [KO:K04735]
7186  
TRAF2; TNF receptor-associated factor 2 [KO:K03173]
6885  
MAP3K7; mitogen-activated protein kinase kinase kinase 7 [KO:K04427] [EC:2.7.11.25]
7189  
TRAF6; TNF receptor-associated factor 6, E3 ubiquitin protein ligase [KO:K03175]
4214  
MAP3K1; mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase [KO:K04416] [EC:2.7.11.25]
5599  
MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]
5602  
MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]
5601  
MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]
5600  
MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]
6300  
MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]
5603  
MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]
1432  
MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]
3576  
IL8; interleukin 8 [KO:K10030]
7124  
TNF; tumor necrosis factor [KO:K03156]
3592  
IL12A; interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) [KO:K05406]
3593  
IL12B; interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) [KO:K05425]
3627  
CXCL10; chemokine (C-X-C motif) ligand 10 [KO:K12671]
7706  
TRIM25; tripartite motif containing 25 [KO:K10652]
1540  
CYLD; cylindromatosis (turban tumor syndrome) [KO:K08601] [EC:3.1.2.15]
54941  
RNF125; ring finger protein 125, E3 ubiquitin protein ligase [KO:K12170] [EC:6.3.2.19]
9636  
ISG15; ISG15 ubiquitin-like modifier [KO:K12159]
9474  
ATG5; autophagy related 5 [KO:K08339]
9140  
ATG12; autophagy related 12 [KO:K08336]
79671  
NLRX1; NLR family member X1 [KO:K12653]
340061  
TMEM173; transmembrane protein 173 [KO:K12654]
55593  
OTUD5; OTU domain containing 5 [KO:K12655] [EC:3.1.2.15]
80143  
SIKE1; suppressor of IKBKE 1 [KO:K12656]
1654  
DDX3X; DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, X-linked [KO:K11594] [EC:3.6.4.13]
8653  
DDX3Y; DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, Y-linked [KO:K11594] [EC:3.6.4.13]
5300  
PIN1; peptidylprolyl cis/trans isomerase, NIMA-interacting 1 [KO:K09578] [EC:5.2.1.8]
26007  
DAK; dihydroxyacetone kinase 2 homolog (S. cerevisiae) [KO:K00863] [EC:2.7.1.29]
Reference
  Authors
Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, Miyagishi M, Taira K, Akira S, Fujita T
  Title
The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses.
  Journal
Nat Immunol 5:730-7 (2004)
Reference
  Authors
Takeuchi O, Akira S
  Title
MDA5/RIG-I and virus recognition.
  Journal
Curr Opin Immunol 20:17-22 (2008)
Reference
  Authors
Yoneyama M, Fujita T
  Title
RNA recognition and signal transduction by RIG-I-like receptors.
  Journal
Immunol Rev 227:54-65 (2009)
Reference
  Authors
Nakhaei P, Genin P, Civas A, Hiscott J
  Title
RIG-I-like receptors: Sensing and responding to RNA virus infection.
  Journal
Semin Immunol (2009)
Reference
  Authors
Moore CB, Ting JP
  Title
Regulation of mitochondrial antiviral signaling pathways.
  Journal
Immunity 28:735-9 (2008)
Reference
  Authors
Barral PM, Sarkar D, Su ZZ, Barber GN, DeSalle R, Racaniello VR, Fisher PB
  Title
Functions of the cytoplasmic RNA sensors RIG-I and MDA-5: key regulators of innate immunity.
  Journal
Pharmacol Ther 124:219-34 (2009)
Reference
  Authors
Schlee M, Hartmann E, Coch C, Wimmenauer V, Janke M, Barchet W, Hartmann G
  Title
Approaching the RNA ligand for RIG-I?
  Journal
Immunol Rev 227:66-74 (2009)
Reference
  Authors
Saito T, Gale M Jr
  Title
Differential recognition of double-stranded RNA by RIG-I-like receptors in antiviral immunity.
  Journal
J Exp Med 205:1523-7 (2008)
Reference
  Authors
Kawai T, Akira S
  Title
Toll-like receptor and RIG-I-like receptor signaling.
  Journal
Ann N Y Acad Sci 1143:1-20 (2008)
Reference
  Authors
Michallet MC, Meylan E, Ermolaeva MA, Vazquez J, Rebsamen M, Curran J, Poeck H, Bscheider M, Hartmann G, Konig M, Kalinke U, Pasparakis M, Tschopp J
  Title
TRADD protein is an essential component of the RIG-like helicase antiviral pathway.
  Journal
Immunity 28:651-61 (2008)
Reference
  Authors
Yoshida R, Takaesu G, Yoshida H, Okamoto F, Yoshioka T, Choi Y, Akira S, Kawai T, Yoshimura A, Kobayashi T
  Title
TRAF6 and MEKK1 play a pivotal role in the RIG-I-like helicase antiviral pathway.
  Journal
J Biol Chem 283:36211-20 (2008)
Reference
  Authors
Mikkelsen SS, Jensen SB, Chiliveru S, Melchjorsen J, Julkunen I, Gaestel M, Arthur JS, Flavell RA, Ghosh S, Paludan SR
  Title
RIG-I-mediated activation of p38 MAPK is essential for viral induction of interferon and activation of dendritic cells: dependence on TRAF2 and TAK1.
  Journal
J Biol Chem 284:10774-82 (2009)
KO pathway
 

DBGET integrated database retrieval system